Company Filing History:
Years Active: 2017-2021
Title: The Innovative Contributions of Inventor Joseph Rosenthal
Introduction
Joseph Rosenthal, an inventive mind based in Ithaca, NY, has made significant strides in the field of biotechnology with his remarkable innovations. Holding three patents, Rosenthal's work focuses on advancing vaccine technology, particularly through probiotic systems that enhance immune responses.
Latest Patents
Joseph Rosenthal’s latest patent is a subunit vaccine delivery platform designed to elicit robust humoral and cellular immune responses. This invention relates to a probiotic cell that has been transformed to overexpress and display on its surface a fusion protein, which comprises a portion of a transport protein coupled with one or more antigenic proteins or peptides. The patent also details probiotic-derived vesicles that exhibit this fusion protein and outlines methods for inducing an immune response using either the probiotic cells or vesicles.
Career Highlights
Rosenthal's career is marked by his role at Cornell University, where he has contributed to groundbreaking research in the fields of microbiology and immunology. His innovative approach to vaccine delivery systems showcases his commitment to improving health outcomes through scientific advancement.
Collaborations
Throughout his career, Rosenthal has collaborated with notable colleagues, including David Putnam and Chung-Jr Huang. These partnerships have been instrumental in driving the research initiatives that lead to his patented technologies and further exploring the potential of probiotics in medicine.
Conclusion
Joseph Rosenthal exemplifies the spirit of innovation within the realm of biotechnology. His patents reflect a significant contribution to the development of new vaccine delivery platforms, potentially transforming the way vaccines elicit immune responses. With continued collaboration and research, Rosenthal’s work can pave the way for future advancements in healthcare.